The T350G Variation of Human Papillomavirus 16 E6 Gene Prevails in Oropharyngeal Cancer from a Small Cohort of Greek Patients
- PMID: 36016346
- PMCID: PMC9415711
- DOI: 10.3390/v14081724
The T350G Variation of Human Papillomavirus 16 E6 Gene Prevails in Oropharyngeal Cancer from a Small Cohort of Greek Patients
Abstract
Recent trends have shown a dramatic rise in the incidence of oropharyngeal squamous cell carcinoma strongly associated with high-risk human papillomavirus (HPV) of type 16. The genetic variability of HPV16 has been extensively studied in cervical cancer but there are very limited published data concerning the genetic variations of this HPV type in oropharyngeal cancer. In the present study, the genetic variations of HPV16 E6 gene sequences originated from a small cohort of Greek patients diagnosed with oropharyngeal cancer were assessed. The vast majority of the sequences clustered within the European variant branch. The T350G variation was found to be the predominant one. This finding may indicate the need for further studies that could explain the possible impact of this variant in the pathomechanisms of oropharyngeal cancer.
Keywords: HPV; Human Papillomavirus; genetic variation; head and neck cancer; type 16.
Conflict of interest statement
All authors declare no conflicts of interest.
Figures

Similar articles
-
Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer.J Natl Cancer Inst. 2017 Aug 1;109(8):djx005. doi: 10.1093/jnci/djx005. J Natl Cancer Inst. 2017. PMID: 28376197 Free PMC article.
-
Genetic variations of E6 and long control region of human papillomavirus type 16 from patients with cervical lesion in Liaoning, China.BMC Cancer. 2013 Oct 7;13:459. doi: 10.1186/1471-2407-13-459. BMC Cancer. 2013. PMID: 24099556 Free PMC article.
-
Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.J Natl Cancer Inst. 2013 Apr 17;105(8):536-45. doi: 10.1093/jnci/djt053. Epub 2013 Mar 16. J Natl Cancer Inst. 2013. PMID: 23503618
-
HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis.Lancet Oncol. 2014 Nov;15(12):1319-31. doi: 10.1016/S1470-2045(14)70471-1. Epub 2014 Oct 16. Lancet Oncol. 2014. PMID: 25439690
-
The role of human papillomavirus in squamous carcinoma of the head and neck.Curr Oncol Rep. 2006 Mar;8(2):130-9. doi: 10.1007/s11912-006-0048-y. Curr Oncol Rep. 2006. PMID: 16507223 Review.
Cited by
-
HPV16 Phylogenetic Variants in Anogenital and Head and Neck Cancers: State of the Art and Perspectives.Viruses. 2024 Jun 3;16(6):904. doi: 10.3390/v16060904. Viruses. 2024. PMID: 38932197 Free PMC article. Review.
-
Insight into Oncogenic Viral Pathways as Drivers of Viral Cancers: Implication for Effective Therapy.Curr Oncol. 2023 Feb 5;30(2):1924-1944. doi: 10.3390/curroncol30020150. Curr Oncol. 2023. PMID: 36826111 Free PMC article. Review.
-
The COVID-19 Pandemic Enhanced Virology Research in Greece.Viruses. 2022 Dec 25;15(1):69. doi: 10.3390/v15010069. Viruses. 2022. PMID: 36680109 Free PMC article.
References
-
- A Suzich J., Ghim S.J., Palmer-Hill F.J., I White W., Tamura J.K., A Bell J., A Newsome J., Jenson A.B., Schlegel R. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc. Natl. Acad. Sci. USA. 1995;92:11553–11557. doi: 10.1073/pnas.92.25.11553. - DOI - PMC - PubMed
-
- PaVE: The Papillomavirus Episteme. [(accessed on 10 July 2022)]; Available online: https://pave.niaid.nih.gov/index.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical